At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 2, 2026 at 17:54 ET
A cluster of insider transactions at Generate Biomedicines (GENB) over the past week includes two open-market purchases totaling $32,000 by executives Mendillo Jane L and Silvers Jason, alongside multiple non-cash derivative conversions by insiders including CEO Michael Nally and others. The purchases are small in absolute value and represent minimal economic activity relative to the company's market cap.
- Two open-market purchases occurred: Mendillo Jane L bought 1,500 shares ($24,000) and Silvers Jason (President & CFO) bought 500 shares ($8,000).
- Multiple non-cash derivative conversions totaling over 26 million shares were executed at $0 value, including by CEO Michael Nally and Stephane Bancel.
- Total open-market buying: $32,000 over 7 days, consistent with recent 30-day activity.
- No open-market selling occurred in the cluster.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access